Cite

HARVARD Citation

    Tré-Hardy, M. et al. (2022). Assessment 2 months after the administration of a 3rd dose mRNA: a new variant-adapted vaccine is expected. Journal of infection. 84 (4), pp. e31-e33. [Online]. 
  
Back to record